Check out more of The BuzzSponsored by: Evodos/Kyte Centrifuge

Synthetic Genomics and IDNA to Develop Synthetic Gene Products

February 6, 2012
AlgaeIndustryMagazine.com

Synthetic Genomics, Inc. (SGI), and Integrated DNA Technologies, Inc. (IDT), the world leader in production and supply of oligonucleotides, have jointly announced that they have entered into an agreement to manufacture, market, and commercialize small synthetic gene products. The financial details of the agreement were not disclosed.

Specifically, SGI and IDT will work together to construct custom, synthetic, double-stranded nucleic acids up to 5 kb. IDT will use its custom oligonucleotide manufacturing expertise, including its recently launched gBlocks Gene Fragments product line, in combination with SGI’s proprietary technologies to efficiently assemble small gene constructs.

“We believe that our agreement with IDT is a key component to advance our synthetic DNA business,” said J. Craig Venter, Ph.D., Founder and Chief Executive Officer, SGI. “We look forward to working with the market leader IDT in developing important products for the life sciences community.”

“We are pleased to be partnering with Synthetic Genomics. Through this collaboration we plan to apply SGI’s cutting edge technologies to create more affordable, efficient gene synthesis products that can be delivered more quickly to the synthetic biology community,” added Dr. Joe Walder, Founder and Chief Executive Officer, IDT.

In May 2010 J. Craig Venter Institute (JCVI) researchers announced the successful construction of the first self-replicating synthetic bacterial cell, work that took years to complete and was enabled only through development of new tools and technologies. SGI sponsored this work at JCVI and controls the licensing of the technologies.

SGI, a privately held company founded in 2005, is dedicated to developing and commercializing genomic-driven solutions to address a wide range of global challenges. The company is focused on several key research and business programs including: developing algae biofuels in alliance with Exxon Mobil Research and Engineering Company, microbial-enhanced hydrocarbon recovery and conversion through an agreement with BP, new and improved food and nutritional products, and clean water technologies.

Go to HOME Page

Copyright ©2010-2012 AlgaeIndustryMagazine.com. All rights reserved. Permission granted to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

Visit the A.I.M. Archives

AIM interview ArchivesAlgae 101 ArchivesHot Products ArchivesInnovations ArchivesMoney ArchivesProcess ArchivesResearch ArchivesScale Up ArchivesThe Buzz Archives

FREE Algae News & Updates

Sign up to receive breaking A.I.M. updates!

Print Friendly

    From the A.I.M. Archives

    Susan M. Kunz, President and Chief Executive Officer of BioVantage, describes herself in part as a “startup addict,” this being her fourth company bui...
    Patents are an integral piece of the overall business plan for companies, universities, and other institutions in developing technologies, as they val...
    As the National Alliance for Advanced Biofuels and Bioproducts, NAABB, comes to the end of the second year in its three-year lifecycle, it’s looking m...
    Rehovot, Israel-based Rosetta Green Ltd., which specializes in crop improvement for the agriculture and alternative fuel industries using unique genes...
    In 2008 David DuByne helped start and run an algae biodiesel company, Dao Energy, LLC, in Chengdu city of Sichuan Province, in western China. Their co...
    A new “Strategy Research Agenda” report from the UK-based Algal Bioenergy Special Interest Group (AB-SIG) highlights the benefits of cultivating and u...